SC Filed 2023-02-27 Event — SEC 0001140361-23-008916 →

VIKING GLOBAL INVESTORS LP → Cazoo Group Ltd

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

15 13D/G filings on this issuer

14 other filings besides this one

Filer Track Record

22 filings by this filer

21 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Cazoo Group Ltd

Filed	Form	Filer	Stake	Shares
2023-11-07	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2023-11-07	SC	Farallon Capital Partners, L.P.	—	—	view →
2023-09-22	SC	Chesterman Alex	—	—	view →
2023-09-22	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2023-05-17	SC	Mubadala Investment Co PJSC	—	—	view →
2023-04-27	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2023-04-27	SC	D1 Capital Partners L.P.	—	—	view →
2023-04-27	SC	INHERENT CREDIT OPPORTUNITIES MASTER, LP	—	—	view →
2023-04-27	SC	Farallon Capital Partners, L.P.	—	—	view →
2022-11-21	SC	Chesterman Alex	—	—	view →
2022-07-12	SC	Rothermere Continuation Ltd	—	—	view →
2022-03-04	SC	Och Daniel	—	—	view →
2022-03-01	SC	D1 Capital Partners L.P.	—	—	view →
2022-02-11	SC	D1 Capital Partners L.P.	—	—	view →

Other Filings by VIKING GLOBAL INVESTORS LP

Filed	Form	Issuer	Stake	Shares
2026-07-10	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	5.00%	9,792,219	view →
2026-06-12	SCHEDULE 13D	STANDARD BIOTOOLS INC. LAB	15.00%	58,651,170	view →
2026-05-18	SCHEDULE 13G	Artiva Biotherapeutics, Inc. ARTV	—	—	view →
2026-04-02	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	6.10%	11,842,434	view →
2025-07-01	SCHEDULE	BridgeBio Pharma, Inc. BBIO	9.80%	18,602,920	view →
2025-01-31	SCHEDULE	BridgeBio Pharma, Inc. BBIO	11.70%	22,055,375	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-09-22	SC	Cazoo Group Ltd	—	—	view →
2023-07-20	SC	BridgeBio Pharma, Inc. BBIO	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →
2022-03-04	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2021-10-01	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-07-12	SC	Myovant Sciences Ltd.	—	—	view →
2019-03-19	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Urovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Showing 20 of 21

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →